Alpha-L-Fucosidase Feed Additives for Antibiotic-Free Gut Health
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current feed additives in livestock production, such as acidifiers, minerals, prebiotics, and probiotics, show low efficacy in replacing antibiotic growth promoters, leading to health and performance issues, increased antibiotic resistance, and high mortality rates, particularly in swine production.
Innovation Solution
Administration of a glycoside hydrolase, specifically alpha-L-fucosidase, to remove alpha-1,2-L-fucose moieties from intestinal mucin layers, promoting the growth of beneficial commensal bacteria like Prevotella spp. and decreasing methanogenic archaea, thereby improving gut health and reducing methane emissions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotic growth promoters are used in livestock production, then animal health and performance are improved, but antibiotic resistance increases
Solution Approach 1:
The patent extracts and removes antibiotic growth promoters from livestock feed, replacing them with glycoside hydrolase enzymes that specifically target and modify intestinal mucin layers. This extraction eliminates the harmful antibiotic resistance effect while maintaining animal health benefits through enzymatic modification of the gut environment.
Solution Approach 2:
The patent introduces glycoside hydrolase enzymes as intermediary substances that mediate between the feed and the animal's gut microbiota. These enzymes modify mucin layers to create a favorable environment for beneficial bacteria without directly using antibiotics, thus achieving health improvement without antibiotic resistance.
2Object-generated harmful factors
If antibiotic growth promoters are discontinued, then antibiotic resistance decreases, but animal mortality increases
Solution Approach 1:
The patent applies preliminary action by administering glycoside hydrolase enzymes before antibiotic discontinuation effects fully manifest. These enzymes pre-modify the intestinal mucin layers to establish a protective microbial environment, preventing the mortality increase that would otherwise occur when antibiotics are removed.
Solution Approach 2:
The patent converts the harmful abrupt cessation of antibiotics into a beneficial transition by using glycoside hydrolase enzymes to gradually reshape the gut environment. This conversion allows the system to benefit from reduced antibiotic resistance while avoiding the harmful mortality spike associated with sudden antibiotic withdrawal.
3Object-generated harmful factors
If current feed additives are used to replace antibiotics, then antibiotic resistance decreases, but efficacy is reduced
Solution Approach 1:
The patent applies parameter changes by fundamentally altering the mechanism of action from direct antibiotic killing to enzymatic modification of mucin layers. This parameter change in the mode of action enables current feed additives to achieve significantly improved efficacy while maintaining reduced antibiotic resistance levels.
Solution Approach 2:
The patent uses composite materials by combining glycoside hydrolase enzymes with feed formulations, creating a synergistic system that enhances the efficacy of feed additives. This composite approach allows the enzymes to work together with other feed components to achieve superior performance compared to conventional additives alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances gut health, increases average daily feed intake, decreases mortality, and improves feed conversion ratio while reducing methane emissions without the use of antibiotics.
Implementation Method 1
administration of an effective amount of a glycoside hydrolase capable of removing at least one alpha-1,2-L-fucose moiety from an intestinal mucin layer
Data Source
AI summary
Provided herein, inter alia, are methods for improving animal health (such as gut health) and performance as well as decreasing methane emissions via administration of an effective amount of a glycoside hydrolase capable of removing at least one alpha-1,2-L-fucose moiety from an intestinal mucin layer. Such methods improve animal health and performance without the need to administer potentially harmful antibiotics to the livestock.